BARCLAYS PLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,495
-25.0%
786,793
+17.6%
0.00%0.0%
Q2 2023$3,327
+34.5%
669,197
+33.7%
0.00%
+100.0%
Q1 2023$2,474
-7.0%
500,651
+18.3%
0.00%0.0%
Q4 2022$2,661
-99.9%
423,053
+33.1%
0.00%
-75.0%
Q3 2022$3,432,000
+880.6%
317,766
+935.8%
0.00%
Q2 2022$350,000
-63.2%
30,679
-70.6%
0.00%
-100.0%
Q1 2022$951,000
-68.2%
104,371
-48.0%
0.00%0.0%
Q4 2021$2,994,000
+166.4%
200,664
+358.7%
0.00%0.0%
Q3 2021$1,124,000
-55.1%
43,750
-54.4%
0.00%0.0%
Q2 2021$2,503,000
-45.2%
95,934
-25.9%
0.00%
-50.0%
Q1 2021$4,571,000
+194.7%
129,518
+110.9%
0.00%
+100.0%
Q4 2020$1,551,000
-48.1%
61,405
-22.6%
0.00%
-50.0%
Q3 2020$2,991,000
-21.2%
79,304
-10.5%
0.00%
-33.3%
Q2 2020$3,795,000
+215.2%
88,611
+43.0%
0.00%
+200.0%
Q1 2020$1,204,000
-3.5%
61,982
+28.9%
0.00%0.0%
Q4 2019$1,248,000
+43.4%
48,086
+50.8%
0.00%0.0%
Q3 2019$870,000
+29.7%
31,889
+27.5%
0.00%
Q2 2019$671,000
-22.7%
25,006
-16.7%
0.00%
-100.0%
Q1 2019$868,000
+3114.8%
30,011
+2949.9%
0.00%
Q4 2018$27,0009840.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders